STOCK TITAN

Outlook Therapeutics, Inc. (OTLK) Net Income by Year

OTLK

Outlook Therapeutics, Inc. reported a net loss of $62.4M in fiscal year 2025. This represents an increase of 17.2% from the prior fiscal year. The table below carries 11 fiscal years, from 2015 to 2025, and the quarters Outlook Therapeutics, Inc. has filed alongside them.

FY2025 annual
Net Income -$62.4M
YoY +17.2%
Source SEC Filings (10-K/10-Q) Latest period Q3 FY2026, ended Jun 30, 2026 Reported Currency USD

Annual figures, oldest first. Point at a bar to read its period.

OTLK Net Income by Fiscal Year

Figures are as reported in USD. Each change compares the year with the year before it, and each column links to the filing it was taken from.

MetricFY2510-KFY2410-KFY2310-KFY2210-KFY2110-KFY2010-KFY1910-KFY1810-KFY1710-KFY1610-KFY1510-K
Net Income-$62.4M+17.2%-$75.4M-27.8%-$59.0M+10.7%-$66.1M-24.2%-$53.2M-50.9%-$35.2M-2.1%-$34.5M-14.7%-$30.1M+22.5%-$38.8M+27.1%-$53.3M-12.5%-$47.4M

OTLK Net Income by Quarter

Figures are as reported in USD. Each change compares the quarter with the same quarter a year earlier.

MetricQ3'2610-QQ2'2610-QQ1'2610-QQ4'2510-QQ3'2510-QQ2'2510-QQ1'2510-QQ4'2410-KQ3'2410-QQ2'2410-QQ1'2410-QQ4'2310-K
Net Income-$20.3M-0.8%-$4.5M+90.4%-$23.1M-232.7%N/A-$20.2M-145.4%-$46.4M+59.4%$17.4M+255.5%N/A$44.4M+314.8%-$114.3M-1617.5%-$11.2M+40.1%N/A

What net income means

Net income is what is left of revenue once every cost is counted, interest and tax included, so a company can grow its sales and still report a loss on this line.

More Outlook Therapeutics, Inc. financials

Frequently Asked Questions

What was Outlook Therapeutics, Inc.'s net income in fiscal year 2025?

Outlook Therapeutics, Inc. reported a net loss of $62.4M in fiscal year 2025.

How fast is Outlook Therapeutics, Inc.'s net income growing?

Outlook Therapeutics, Inc. (OTLK) net income rose by 17.2% year over year, from -$75.4M to -$62.4M in fiscal year 2025.

How has Outlook Therapeutics, Inc.'s net income changed over the years?

Across the 11 fiscal years this page covers, Outlook Therapeutics, Inc. (OTLK) net income went from -$47.4M in fiscal year 2015 to -$62.4M in fiscal year 2025.

Outlook Therapeutics, Inc. (OTLK) reported -$20.3M in net income in Q3 2026. This represents a decrease of 0.8% from the same quarter a year earlier.

Net income is what is left of revenue once every cost is counted, interest and tax included, so a company can grow its sales and still report a loss on this line. This page lists what Outlook Therapeutics, Inc. (OTLK) reported on that line in every period on record.